These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 26840568)
1. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection. Dumstrei K; Chen H; Brenner H Oncotarget; 2016 Mar; 7(10):11151-64. PubMed ID: 26840568 [TBL] [Abstract][Full Text] [Related]
2. Blood autoantibodies against tumor-associated antigens as biomarkers in early detection of colorectal cancer. Chen H; Werner S; Tao S; Zörnig I; Brenner H Cancer Lett; 2014 May; 346(2):178-87. PubMed ID: 24462820 [TBL] [Abstract][Full Text] [Related]
3. Serum autoantibodies in the early detection of esophageal cancer: a systematic review. Zhang H; Xia J; Wang K; Zhang J Tumour Biol; 2015 Jan; 36(1):95-109. PubMed ID: 25433500 [TBL] [Abstract][Full Text] [Related]
4. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis. Shi JX; Qin JJ; Ye H; Wang P; Wang KJ; Zhang JY Expert Rev Mol Diagn; 2015 Jun; 15(6):829-52. PubMed ID: 25959246 [TBL] [Abstract][Full Text] [Related]
5. Systematic review: serum autoantibodies in the early detection of gastric cancer. Werner S; Chen H; Tao S; Brenner H Int J Cancer; 2015 May; 136(10):2243-52. PubMed ID: 24615018 [TBL] [Abstract][Full Text] [Related]
6. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study. Bracci PM; Zhou M; Young S; Wiemels J Cancer; 2012 Nov; 118(21):5384-94. PubMed ID: 22517435 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer. Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480 [TBL] [Abstract][Full Text] [Related]
8. Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers. Ummanni R; Duscharla D; Barett C; Venz S; Schlomm T; Heinzer H; Walther R; Bokemeyer C; Brümmendorf TH; Murthy PV; Balabanov S J Proteomics; 2015 Apr; 119():218-29. PubMed ID: 25724726 [TBL] [Abstract][Full Text] [Related]
9. Autoantibody biomarker opens a new gateway for cancer diagnosis. Nesterova M; Johnson N; Cheadle C; Cho-Chung YS Biochim Biophys Acta; 2006 Apr; 1762(4):398-403. PubMed ID: 16483750 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies: Opportunities for Early Cancer Detection. Macdonald IK; Parsy-Kowalska CB; Chapman CJ Trends Cancer; 2017 Mar; 3(3):198-213. PubMed ID: 28718432 [TBL] [Abstract][Full Text] [Related]
11. Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma. Xu YW; Peng YH; Xu LY; Xie JJ; Li EM World J Gastroenterol; 2019 Sep; 25(34):5049-5068. PubMed ID: 31558856 [TBL] [Abstract][Full Text] [Related]
12. Autoantibody biomarkers for the detection of serous ovarian cancer. Katchman BA; Chowell D; Wallstrom G; Vitonis AF; LaBaer J; Cramer DW; Anderson KS Gynecol Oncol; 2017 Jul; 146(1):129-136. PubMed ID: 28427776 [TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting. Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861 [TBL] [Abstract][Full Text] [Related]
14. Serum autoantibodies as biomarkers for early cancer detection. Tan HT; Low J; Lim SG; Chung MC FEBS J; 2009 Dec; 276(23):6880-904. PubMed ID: 19860826 [TBL] [Abstract][Full Text] [Related]
15. Autoantibody profiles as biomarkers of breast cancer. Tabernero MD; Lv LL; Anderson KS Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085 [TBL] [Abstract][Full Text] [Related]
16. Serum Protein Markers for the Early Detection of Lung Cancer: A Focus on Autoantibodies. Broodman I; Lindemans J; van Sten J; Bischoff R; Luider T J Proteome Res; 2017 Jan; 16(1):3-13. PubMed ID: 27769114 [TBL] [Abstract][Full Text] [Related]
17. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer. Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of paraneoplastic antigens reveals TRIM21 autoantibodies as biomarker for early detection of ovarian cancer in combination with autoantibodies to NY-ESO-1 and TP53. Hurley LC; Levin NK; Chatterjee M; Coles J; Muszkat S; Howarth Z; Dyson G; Tainsky MA Cancer Biomark; 2020; 27(3):407-421. PubMed ID: 32083570 [TBL] [Abstract][Full Text] [Related]
19. Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. Tang ZM; Ling ZG; Wang CM; Wu YB; Kong JL PLoS One; 2017; 12(7):e0182117. PubMed ID: 28750095 [TBL] [Abstract][Full Text] [Related]
20. Tumor-associated autoantibody signature for the early detection of gastric cancer. Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]